Related references
Note: Only part of the references are listed.Doxorubicin induces cardiomyocyte apoptosis and atrophy through cyclin-dependent kinase 2?mediated activation of forkhead box O1
Peng Xia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221)
Christine B. Ambrosone et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Major cardiac events for adult survivors of childhood cancer diagnosed between 1970 and 1999: report from the Childhood Cancer Survivor Study cohort
Daniel A. Mulrooney et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy
Kendall B. Wallace et al.
CIRCULATION RESEARCH (2020)
Doxorubicin Induces Endotheliotoxicity and Mitochondrial Dysfunction via ROS/eNOS/NO Pathway
Huan He et al.
FRONTIERS IN PHARMACOLOGY (2020)
Luteolin Attenuates Doxorubicin-Induced Cardiotoxicity Through Promoting Mitochondrial Autophagy
Haixia Xu et al.
FRONTIERS IN PHYSIOLOGY (2020)
Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity
Tomonori Tadokoro et al.
JCI INSIGHT (2020)
Circulating Levels of Epirubicin Cause Endothelial Senescence While Compromising Metabolic Activity and Vascular Function
Amanda J. Eakin et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Doxorubicin-Induced Oxidative Stress and Endothelial Dysfunction in Conduit Arteries Is Prevented by Mitochondrial-Specific Antioxidant Treatment
Zachary S. Clayton et al.
JACC: CARDIOONCOLOGY (2020)
Doxorubicin Exposure Causes Subacute Cardiac Atrophy Dependent on the Striated Muscle-Specific Ubiquitin Ligase MuRF1
Monte S. Willis et al.
CIRCULATION-HEART FAILURE (2019)
Therapy-Related Cardiac Risk in Childhood Cancer Survivors: An Analysis of the Childhood Cancer Survivor Study
James E. Bates et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Ferroptosis as a target for protection against cardiomyopathy
Xuexian Fang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Twist and TurnTopoisomerase Functions in Mitochondrial DNA Maintenance
Steffi Goffart et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Ibudilast attenuates doxorubicin-induced cytotoxicity by suppressing formation of TRPC3 channel and NADPH oxidase 2 protein complexes
Kazuhiro Nishiyama et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors: A Scientific Statement From the American Heart Association
Susan C. Gilchrist et al.
CIRCULATION (2019)
L-arginine alleviates doxorubicin-induced endothelium-dependent dysfunction by promoting nitric oxide generation and inhibiting apoptosis
Xunan Li et al.
TOXICOLOGY (2019)
Oxidative stress injury in doxorubicin-induced cardiotoxicity
Mei Songbo et al.
TOXICOLOGY LETTERS (2019)
Blockade of L-type Ca2+ channel attenuates doxorubicin-induced cardiomyopathy via suppression of CaMKII-NF-κB pathway
Soichiro Ikeda et al.
SCIENTIFIC REPORTS (2019)
p53 prevents doxorubicin cardiotoxicity independently of its prototypical tumor suppressor activities
Jie Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Occurrence of Treatment-Related Cardiotoxicity and Its Impact on Outcomes Among Children Treated in the AAML0531 Clinical Trial: A Report From the Children's Oncology Group
Kelly D. Getz et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Exercise Attenuates Cardiotoxicity of Anthracycline Chemotherapy Measured by Global Longitudinal Strain
Benedict T. Costello et al.
JACC: CARDIOONCOLOGY (2019)
Left Ventricular Mass Change After Anthracycline Chemotherapy
Jennifer H. Jordan et al.
CIRCULATION-HEART FAILURE (2018)
CRTH2 promotes endoplasmic reticulum stress-induced cardiomyocyte apoptosis through m-calpain
Shengkai Zuo et al.
EMBO MOLECULAR MEDICINE (2018)
Efficacy of Exercise Therapy on Cardiorespiratory Fitness in Patients With Cancer: A Systematic Review and Meta-Analysis
Jessica M. Scott et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Anthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease
Thiago Ferreira de Souza et al.
JACC-CARDIOVASCULAR IMAGING (2018)
When Left Ventricular Extracellular Volume Fraction Changes After Anthracyclines Is it Due to a Change in the Numerator, Denominator, or Both?
W. Gregory Hundley et al.
JACC-CARDIOVASCULAR IMAGING (2018)
Anthracyclines as Topoisomerase II Poisons: From Early Studies to New Perspectives
Jessica Marinello et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Native myocardial T1 time can predict development of subsequent anthracycline-induced cardiomyopathy
Fabian Muehlberg et al.
ESC HEART FAILURE (2018)
Exome array analysis identifies ETFB as a novel susceptibility gene for anthracycline-induced cardiotoxicity in cancer patients
Sara Ruiz-Pinto et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Carvedilol Prevents Redox Inactivation of Cardiomyocyte β1-Adrenergic Receptors
Misun Park et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2018)
Interventions for preventing cardiomyopathy due to anthracyclines: a Bayesian network meta-analysis
H. Abdel-Qadir et al.
ANNALS OF ONCOLOGY (2017)
Cardioprotective Effects of Carvedilol in Inhibiting Doxorubicin-induced Cardiotoxicity
Maryam Nabati et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2017)
Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients With Breast Cancer
Brian S. Finkelman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Oxidative Stress and Cellular Response to Doxorubicin: A Common Factor in the Complex Milieu of Anthracycline Cardiotoxicity
Donato Cappetta et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Modulation of caveolins, integrins and plasma membrane repair proteins in anthracycline-induced heart failure in rabbits
Yasuhiro Ichikawa et al.
PLOS ONE (2017)
Statins in anthracycline-induced cardiotoxicity: Rac and Rho, and the heartbreakers
Christian Henninger et al.
CELL DEATH & DISEASE (2017)
Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity
Navid Koleini et al.
ONCOTARGET (2017)
Early Detection and Serial Monitoring of Anthracycline-Induced Cardiotoxicity Using T1-mapping Cardiac Magnetic Resonance Imaging: An Animal Study
Yoo Jin Hong et al.
SCIENTIFIC REPORTS (2017)
Blood Pressure Status in Adult Survivors of Childhood Cancer: A Report from the St. Jude Lifetime Cohort Study
Todd M. Gibson et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Brent R. Stockwell et al.
CELL (2017)
The role of sirtuins in mitochondrial function and doxorubicin-induced cardiac dysfunction
Vernon W. Dolinsky
BIOLOGICAL CHEMISTRY (2017)
TRPC3-Nox2 complex mediates doxorubicin-induced myocardial atrophy
Tsukasa Shimauchi et al.
JCI INSIGHT (2017)
Detailed Echocardiographic Phenotyping in Breast Cancer Patients: Associations With Ejection Fraction Decline, Recovery, and Heart Failure Symptoms Over 3 Years of Follow-Up
Hari K. Narayan et al.
CIRCULATION (2017)
Anthracycline Chemotherapy and Cardiotoxicity
John V. McGowan et al.
CARDIOVASCULAR DRUGS AND THERAPY (2017)
Cardioprotection and Second Malignant Neoplasms Associated With Dexrazoxane in Children Receiving Anthracycline Chemotherapy: A Systematic Review and Meta-Analysis
Furqan Shaikh et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Cardioprotection and Second Malignant Neoplasms Associated With Dexrazoxane in Children Receiving Anthracycline Chemotherapy: A Systematic Review and Meta-Analysis
Furqan Shaikh et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
miR-320a mediates doxorubicin-induced cardiotoxicity by targeting VEGF signal pathway
Zhongwei Yin et al.
AGING-US (2016)
Sirt3 protects mitochondrial DNA damage and blocks the development of doxorubicin-induced cardiomyopathy in mice
Vinodkumar B. Pillai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2016)
New signal transduction paradigms in anthracycline-induced cardiotoxicity
Alessandra Ghigo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity
Folefac Aminkeng et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification
Dan L. Li et al.
CIRCULATION (2016)
Cardio-Oncology An Update on Cardiotoxicity of Cancer-Related Treatment
Carrie G. Lenneman et al.
CIRCULATION RESEARCH (2016)
Chemical Endoplasmic Reticulum Chaperone Alleviates Doxorubicin-Induced Cardiac Dysfunction
Hai Ying Fu et al.
CIRCULATION RESEARCH (2016)
Anthracycline-Associated T1 Mapping Characteristics Are Elevated Independent of the Presence of Cardiovascular Comorbidities in Cancer Survivors
Jennifer H. Jordan et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2016)
Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 x 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
Geeta Gulati et al.
EUROPEAN HEART JOURNAL (2016)
Ramipril restores PPARβ/δ and PPARγ expressions and reduces cardiac NADPH oxidase but fails to restore cardiac function and accompanied myosin heavy chain ratio shift in severe anthracycline-induced cardiomyopathy in rat
Hana Cernecka et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
SIRT1 activation attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of anthracycline cardiomyopathy
Donato Cappetta et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity
Paul W. Burridge et al.
NATURE MEDICINE (2016)
Ventricular-Arterial Coupling in Breast Cancer Patients After Treatment With Anthracycline-Containing Adjuvant Chemotherapy
Graeme J. Koelwyn et al.
ONCOLOGIST (2016)
Assessment of brachial artery reactivity, carotid intima-media thickness, and adhesion molecules in pediatric solid tumor patients treated with anthracyclines
Arzu Okur et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2016)
Evidence for association of SNPs in ABCB1 and CBR3, but not RAC2, NCF4, SLC28A3 or TOP2B, with chronic cardiotoxicity in a cohort of breast cancer patients treated with anthracyclines
Daniel L. Hertz et al.
PHARMACOGENOMICS (2016)
VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection
Markus Rasanen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Noninvasive Measures of Ventricular-Arterial Coupling and Circumferential Strain Predict Cancer Therapeutics-Related Cardiac Dysfunction
Hari K. Narayan et al.
JACC-CARDIOVASCULAR IMAGING (2016)
Gp130-mediated STAT3 activation by S-propargyl-cysteine, an endogenous hydrogen sulfide initiator, prevents doxorubicin-induced cardiotoxicity
J. Wu et al.
CELL DEATH & DISEASE (2016)
TRPC3 positively regulates reactive oxygen species driving maladaptive cardiac remodeling
Naoyuki Kitajima et al.
SCIENTIFIC REPORTS (2016)
Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients
Christof Vulsteke et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
Daniela Cardinale et al.
CIRCULATION (2015)
Early and late changes in markers of aortic stiffness with breast cancer therapy
S. Grover et al.
INTERNAL MEDICINE JOURNAL (2015)
Individual Prediction of Heart Failure Among Childhood Cancer Survivors
Eric J. Chow et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer
Folefac Aminkeng et al.
NATURE GENETICS (2015)
Association of NADPH oxidase polymorphisms with anthracycline-induced cardiotoxicity in the RICOVER-60 trial of patients with aggressive CD20+ B-cell lymphoma
Annegret Reichwagen et al.
PHARMACOGENOMICS (2015)
Genetic variants in SLC22A17 and SLC22A7 are associated with anthracycline-induced cardiotoxicity in children
Henk Visscher et al.
PHARMACOGENOMICS (2015)
NADPH oxidases: an overview from structure to innate immunity-associated pathologies
Arvind Panday et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK
Xue Wang et al.
BIOCHEMICAL PHARMACOLOGY (2014)
P53 inhibition exacerbates late-stage anthracycline cardiotoxicity
Wuqiang Zhu et al.
CARDIOVASCULAR RESEARCH (2014)
Longitudinal Assessment of Concurrent Changes in Left Ventricular Ejection Fraction and Left Ventricular Myocardial Tissue Characteristics After Administration of Cardiotoxic Chemotherapies Using T1-Weighted and T2-Weighted Cardiovascular Magnetic Resonance
Jennifer H. Jordan et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2014)
The Many Functions of the Endoplasmic Reticulum Chaperones and Folding Enzymes
Laura Halperin et al.
IUBMB LIFE (2014)
Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
Yoshihiko Ichikawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Hyaluronan Synthase 3 Variant and Anthracycline-Related Cardiomyopathy: A Report From the Children's Oncology
Xuexia Wang et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
We Have Contact: Endothelial Cell-Smooth Muscle Cell Interactions
Brenda Lilly
PHYSIOLOGY (2014)
Genetic susceptibility to anthracycline-related congestive heart failure in survivors of haematopoietic cell transplantation
Saro H. Armenian et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Impact of Hemochromatosis Gene Mutations on Cardiac Status in Doxorubicin-Treated Survivors of Childhood High-Risk Leukemia
Steven E. Lipshultz et al.
CANCER (2013)
Quantification of Cardiomyocyte Hypertrophy by Cardiac Magnetic Resonance Implications for Early Cardiac Remodeling
Otavio R. Coelho-Filho et al.
CIRCULATION (2013)
Modifiable Risk Factors and Major Cardiac Events Among Adult Survivors of Childhood Cancer
Gregory T. Armstrong et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients With Malignant Hemopathies
Xavier Bosch et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Clyde W. Yancy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial
John R. Mackey et al.
LANCET ONCOLOGY (2013)
The role of autophagy in doxorubicin-induced cardiotoxicity
Amie J. Dirks-Naylor
LIFE SCIENCES (2013)
Association of Anthracycline-Related Cardiac Histological Lesions With NADPH Oxidase Functional Polymorphisms
Almudena Cascales et al.
ONCOLOGIST (2013)
Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children
H. Visscher et al.
PEDIATRIC BLOOD & CANCER (2013)
Low to Moderate Dose Anthracycline-Based Chemotherapy Is Associated With Early Noninvasive Imaging Evidence of Subclinical Cardiovascular Disease
Brandon C. Drafts et al.
JACC-CARDIOVASCULAR IMAGING (2013)
Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling
Edythe B. Tham et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2013)
Left Ventricular Mass in Patients With a Cardiomyopathy After Treatment With Anthracyclines
Tomas G. Neilan et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Endothelial vascular toxicity from chemotherapeutic agents: Preclinical evidence and clinical implications
Aspasia Soultati et al.
CANCER TREATMENT REVIEWS (2012)
Decline in the Use of Anthracyclines for Breast Cancer
Sharon H. Giordano et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children
Henk Visscher et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes-A Report From the Children's Oncology Group
Javier G. Blanco et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Effect of Statin Therapy on the Risk for Incident Heart Failure in Patients With Breast Cancer Receiving Anthracycline Chemotherapy An Observational Clinical Cohort Study
Sinziana Seicean et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Sui Zhang et al.
NATURE MEDICINE (2012)
Mitochondria as sensors and regulators of calcium signalling
Rosario Rizzuto et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation
Saro H. Armenian et al.
BLOOD (2011)
The iron chelator Dp44mT inhibits the proliferation of cancer cells but fails to protect from doxorubicin-induced cardiotoxicity in spontaneously hypertensive rats
V. Ashutosh Rao et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Cardiomyocyte NF-kappa B p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure
Tariq Hamid et al.
CARDIOVASCULAR RESEARCH (2011)
Modulation of Anthracycline-Induced Cardiotoxicity by Aerobic Exercise in Breast Cancer Current Evidence and Underlying Mechanisms
Jessica M. Scott et al.
CIRCULATION (2011)
Multiple Facets of NF-κB in the Heart To Be or Not to NF-κB
Joseph W. Gordon et al.
CIRCULATION RESEARCH (2011)
Efficiency of Atorvastatin in the Protection of Anthracycline-Induced Cardiomyopathy
Zeydin Acar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
X-ROS Signaling: Rapid Mechano-Chemo Transduction in Heart
Benjamin L. Prosser et al.
SCIENCE (2011)
Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study
Jennifer L. Patnaik et al.
BREAST CANCER RESEARCH (2011)
Short-term exercise training protects against doxorubicin-induced cardiac mitochondrial damage independent of HSP72
Andreas N. Kavazis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Nox2 NADPH Oxidase Promotes Pathologic Cardiac Remodeling Associated with Doxorubicin Chemotherapy
Youyou Zhao et al.
CANCER RESEARCH (2010)
Pathology of late-onset anthracycline cardiomyopathy
Bob N. Bernaba et al.
CARDIOVASCULAR PATHOLOGY (2010)
Aortic Stiffness Increases Upon Receipt of Anthracycline Chemotherapy
Narumol Chaosuwannakit et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Muscle ring finger 1 mediates cardiac atrophy in vivo
Monte S. Willis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro
Partha Mukhopadhyay et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Mitochondrial DNA is a direct target of anti-cancer anthracycline drugs
Neil Ashley et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Acute Doxorubicin Cardiotoxicity Is Associated With p53-Induced Inhibition of the Mammalian Target of Rapamycin Pathway
Wuqiang Zhu et al.
CIRCULATION (2009)
Late Mortality Among 5-Year Survivors of Childhood Cancer: A Summary From the Childhood Cancer Survivor Study
Gregory T. Armstrong et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21
D. Rossi et al.
LEUKEMIA (2009)
Function of Mitochondrial Stat3 in Cellular Respiration
Joanna Wegrzyn et al.
SCIENCE (2009)
Subclinical late cardiac toxicity in childhood cancer survivors - Impact on self-reported health
Cheryl L. Cox et al.
CANCER (2008)
The PGE2-Stat3 interaction in doxorubicin-induced myocardial apoptosis
Miguel A. Frias et al.
CARDIOVASCULAR RESEARCH (2008)
The unfolded protein response regulator GRP78/BiP is required for endoplasmic reticulum integrity and stress-induced autophagy in mammalian cells
J. Li et al.
CELL DEATH AND DIFFERENTIATION (2008)
Effects of physical exercise on myocardial telomere-regulating proteins, survival pathways, and apoptosis
Christian Werner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Vascular dysfunction in adriamycin nephrosis: different effects of adriamycin exposure and nephrosis
Nadir Ulu et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Ghrelin prevents doxorubicin-induced cardiotoxicity through TNF-alpha/NF-κB pathways and mitochondrial protective mechanisms
Zhiwei Xu et al.
TOXICOLOGY (2008)
Endoplasmic reticulum stress in the heart
Christopher C. Glembotski
CIRCULATION RESEARCH (2007)
Topoisomerase IIβ-Mediated DNA double-strand breaks:: Implications in doxorubicin cardiotoxicity and prevention by dexrazoxane
Yi Lisa Lyu et al.
CANCER RESEARCH (2007)
Acute cardiac functional and morphological changes after Anthracycline infusions in children
Javier Ganame et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Role of mtDNA lesions in anthracycline cardiotoxicity
Dirk Lebrecht et al.
CARDIOVASCULAR TOXICOLOGY (2007)
Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide
J. Damrot et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition
Daniela Cardinale et al.
CIRCULATION (2006)
Protective effects of carvedilol against anthracycline-induced cardiomyopathy
Nihat Kalay et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
DNA damage is an early event in doxorubicin-induced cardiac myocyte death
Thomas L'Ecuyer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Multicenter randomized phase III study of the cardioprotective effect of dexrazoxane (Cardioxane®) in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapy
M Marty et al.
ANNALS OF ONCOLOGY (2006)
Signal transducers and activators of transcription (STATs): Novel targets of chemopreventive and chemotherapeutic drugs
L Klampfer
CURRENT CANCER DRUG TARGETS (2006)
The anti-cancer drug, doxorubicin, causes oxidant stress-induced endothelial dysfunction
MB Wolf et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2006)
NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity
L Wojnowski et al.
CIRCULATION (2005)
NAD(P)H oxidase 4 mediates transforming growth factor-β1-induced differentiation of cardiac fibroblasts into myofibroblasts
I Cucoranu et al.
CIRCULATION RESEARCH (2005)
Molecular pharmacology of the interaction of anthracyclines with iron
XX Xu et al.
MOLECULAR PHARMACOLOGY (2005)
Pathology of radiation and anthracycline cardiotoxicity
GJ Berry et al.
PEDIATRIC BLOOD & CANCER (2005)
Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice
Y Shizukuda et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2005)
Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia
SE Lipshultz et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
ATP flux through creatine kinase in the normal, stressed, and failing human heart
RG Weiss et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
TGF-β signaling and the fibrotic response
A Leask et al.
FASEB JOURNAL (2004)
Functional compatibility between isoform α and β of type II DNA topoisomerase
A Sakaguchi et al.
JOURNAL OF CELL SCIENCE (2004)
Anthracyclines induce calpain-dependent titin proteolysis and necrosis in cardiomyocytes
CC Lim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin
CJ Miranda et al.
BLOOD (2003)
A truncated form of DNA topoisomerase IIβ associates with the mtDNA genome in mammalian mitochondria
RL Low et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2003)
Rapid-onset endothelial dysfunction with adriamycin: evidence for a dysfunctional nitric oxide synthase
D Duquaine et al.
VASCULAR MEDICINE (2003)
Adriamycin-induced cardiomyocyte and endothelial cell apoptosis:: In vitro and in vivo studies
S Wu et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2002)
Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer
SE Lipshultz et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Activation of nuclear factor-κB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic:: the role of hydrogen peroxide
SW Wang et al.
BIOCHEMICAL JOURNAL (2002)
Doxorubicin-induced apoptosis is associated with increased transcription of endothelial nitric-oxide synthase - Effect of antiapoptotic antioxidants and calcium
SV Kalivendi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Potential protective role of angiotensin-converting enzyme inhibitors captopril and enalapril against adriamycin-induced acute cardiac and hepatic toxicity in rats
MAA El-Aziz et al.
JOURNAL OF APPLIED TOXICOLOGY (2001)
Chronic effect of doxorubicin on vascular endothelium assessed by organ culture study
T Murata et al.
LIFE SCIENCES (2001)
The human ATP-binding cassette (ABC) transporter superfamily
M Dean et al.
GENOME RESEARCH (2001)
Chronic vascular toxicity of doxorubicin in an organ-cultured artery
T Murata et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy.
GM Felker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy
K Kunisada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
